Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
Clinical trial NCT00130442 · COMPLETED
Trial details
- NCT number
- NCT00130442
- Sponsor
- Cellxpert Biotechnology Corp.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2010-10-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.